Protective effects of linagliptin and tenofovir disoproxil fumarate against APAP-induced acute liver injury: A biochemical, histological, and computational study
Linagliptin and tenofovir disoproxil fumarate reduce acute liver injury effectively and biochemically.
Key evidence shows significant liver protection following APAP-induced injury, with noted biochemical improvements.
Analysis employs biochemical and histological assessments, alongside computational modeling to evaluate protective effects.
Findings highlight the potential for these drugs to be used in treating acute liver conditions, warranting further investigation for clinical applications.